Creatine Biosynthesis Disorders Panel, Urine
Test Code
Clinical Significance
Creatine Biosynthesis Disorders Panel, Urine - The intended use for this test is as a means of evaluating patients with a suspected inherited disorder of creatine metabolism. The cerebral creatine deficiency syndromes (CCDS), inborn errors of creatine metabolism, include the two creatine biosynthesis disorders (guanidinoacetate methyltransferase [GAMT] deficiency and L-arginine: glycine amidinotransferase [AGAT or GATM] deficiency), and the X-linked creatine transporter [SLC6A8] deficiency. Intellectual disability and seizures are common to all three CCDS. The majority of individuals with GAMT deficiency have a behavior disorder that can include ...
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
Reference Range(s)
Alternative Name(s)
Preferred Specimen(s)
1 mL random urine collected in a sterile cup or tube (including catheter submissions)
Alternative Specimen(s)
24-hour urine
Minimum Volume
0.15 mL
Collection Instructions
Collect a random urine specimen. Immediately freeze specimen. Correct specimen collection and handling is crucial to achieve reliable results.
Transport Container
Sterile plastic urine container
Transport Temperature
Frozen
Specimen Stability
- Room temperature: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 28 days
Reject Criteria
Specimens not frozen immediately after collection
Setup Schedule
Refrigerated: Unacceptable
Frozen: 28 days